ophthalmology

Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology
BioSpace
Wed, 05/29/24 - 11:54 am
Merck
EyeBio
ophthalmology
M&A
Busy with 3 program launches this year, Biogen trims pipeline
Fierce Biotech
Tue, 04/25/23 - 11:40 am
Biogen
stroke
gene therapy
ophthalmology
earnings
After $3.4B deal and EU withdrawal, Novartis looks to sell Xiidra
Fierce Pharma
Tue, 03/14/23 - 11:30 am
Novartis
Xiidra
ophthalmology
Coherus pays out $32M for exclusive US commercialization rights to Eylea biosimilar
Endpoints
Tue, 01/10/23 - 06:40 pm
Coherus Biosciences
biosimilars
ophthalmology
Eylea
Regeneron
Biosimilars hit a turning point as they expand outside oncology
Clinical Trials Arena
Fri, 12/9/22 - 10:31 am
biosimilars
oncology
immunology
gastroenterology
ophthalmology
Respiratory
dermatology
metabolic disorders
musculoskeletal disorders
Novartis weighs sale of ophthalmology, respiratory units
Yahoo/Reuters
Wed, 11/16/22 - 12:05 pm
Novartis
Respiratory
ophthalmology
Five things to watch as the Biosimilars market heats up in 2022
Pharmaforum
Fri, 04/1/22 - 10:40 am
biosimilars
Humira
Semglee
innovations
ophthalmology
Bausch Health takes option to buy all ophthalmology assets of Allegro
Pharma Letter
Mon, 09/21/20 - 10:53 am
Bausch Health
Allergro Ophthalmics
ophthalmology
SIFI reports positive results from 044/si phase 3 clinical trial further highlighting strength of its NETILDEX® franchise
CP WIre
Tue, 08/25/20 - 01:29 pm
SIFI
ophthalmology
clinical trials
Netildex
cataract surgery
Verily plans digital ophthalmology joint venture with Santen
Pharmaforum
Thu, 02/6/20 - 11:35 pm
Verily
Santen
Japan
digital ophthalmology
ophthalmology
Alphabet
Biogen signs marketing deal for two ophthalmology biosimilars
Pharmaforum
Thu, 11/7/19 - 10:16 am
Biogen
ophthalmology
biosimilars
Europe
Japan
Samsung Bioepis
SB11
SB15
Lucentis
Eylea
SIFI announces expansion on the French market with the acquisition of DACUDOSES® and NOVOPTINE®
CP Wire
Mon, 07/8/19 - 10:45 am
SIFI
Italy
France
M&A
ophthalmology
Dacudoses
Novoptine
SIFI announces expansion on the French market with the acquisition of DACUDOSES® and NOVOPTINE®
Mon, 07/8/19 - 10:46 am
SIFI
Italy
France
M&A
ophthalmology
Dacudoses
Novoptine
Biogen to acquire ophthalmology gene therapy play Nightstar
BioCentury
Mon, 03/4/19 - 10:37 am
Biogen
M&A
Nightstar Therapeutics
gene therapy
ophthalmology
NTC acquires part of Novartis’ ophthalmic portfolio
GoinPharma
Sat, 06/2/18 - 01:46 pm
Novartis
NTC
ophthalmology
M&A
Biopharma trends to watch in 2018
BioPharma Dive
Sat, 12/23/17 - 11:45 pm
drug pricing
M&A
gene therapy
biosimilars
opioids
ophthalmology
J&J Vision to acquire TearScience
Mass Device
Mon, 08/7/17 - 11:28 am
JNJ
TearScience
M&A
eye health
ophthalmology
Astellas to Acquire Ocata Therapeutics
Yahoo
Tue, 11/10/15 - 08:36 am
Astellas
Ocata Therapeutics
M&A
ophthalmology
Shire chief Ornskov bets $300M on another eye drug bolt-on buyout
Fierce Biotech
Mon, 08/3/15 - 08:53 am
Shire
Flemming Ornskov
M&A
FST-100
ophthalmology
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst
Seeking Alpha
Tue, 12/3/13 - 11:04 am
pSivida
ophthalmology
GSK
Novartis
Pfizer
Regeneron
Roche
Sanofi
Iluvien
Durasert
Medidur

Pages